3 completed. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Vivaglobin: new trials by email Literature Review of Vivaglobin trials Research Report on Vivaglobin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retrospective Chart Review of Subcutaneous IgG Use in Infants Subcutaneous IgG (SCIG) - Primary Immune Deficiency | Completed | CSL Behring | 27 | 2010-05-01 | 2011-02-11 | |
| A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN) Vivaglobin - Multifocal Motor Neuropathy (MMN) | Phase 2 | Completed | CSL Behring | 8 | 2007-11-01 | 2013-08-01 |
| Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Vivaglobin - Common Variable Immunodeficiency, Agammaglobulinemia | Phase 4 | Completed | CSL Behring | 18 | 2007-03-01 | 2013-06-20 |
Primary Immunodeficiency Diseases (2) · Agammaglobulinemia (1) · Bruton type agammaglobulinemia (1) · Common Variable Immunodeficiency (1)
CSL Behring (3)
Italy (2) · Canada (1) · Germany (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Bernd Kieseier, MD (1) · Giancarlo Comi, MD (1) · Matthias Sturzenegger, MD (1) · Melvin Berger, MD, PhD (1) · Michael Borte, MD (1) · Siraj Misbah, MD (1)